Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for RZLT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
March 31, 2026 -0.747M
December 31, 2025 -0.356M
September 30, 2025 -0.911M
June 30, 2025 -101.16M
March 31, 2025 -0.01M
December 31, 2024 -0.657M
September 30, 2024 -5.50M
June 30, 2024 -63.32M
March 31, 2024 0.00
December 31, 2023 0.293M
September 30, 2023 0.00
June 30, 2023 0.759M
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 -12.33M
June 30, 2022 -111.82M
March 31, 2022 0.00
December 31, 2021 -50.74M
September 30, 2021 -2.69M
June 30, 2021 0.05M
March 31, 2021 0.139M
December 31, 2020 -37.46M
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
Date Value
December 31, 2019 0.021M
September 30, 2019 -22.57M
June 30, 2019 23.50M
March 31, 2019 -23.50M
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 -4.44M
June 30, 2017 -3.776M
March 31, 2017 -4.50M
December 31, 2016 -3.322M
September 30, 2016 -2.356M
June 30, 2016 -5.809M
March 31, 2016 -3.116M
December 31, 2015 -1.894M
September 30, 2015 0.00
June 30, 2015 -1.273M
March 31, 2015 -2.624M
December 31, 2014 -6.207M
September 30, 2014 0.00
June 30, 2014 4.121M
March 31, 2014 -4.121M
December 31, 2013 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. -38.83M
AbbVie, Inc. 9.00M
Marker Therapeutics, Inc. 0.00
Avalo Therapeutics, Inc. -410.21M
Krystal Biotech, Inc. -15.16M